Need professional-grade analysis? Visit stockanalysis.com
$39.14B
30.18
9,073
0.48%
Price Chart
Risk-Adjusted Performance
Fujian Wanchen Biotechnology Co. Ltd (300972) Price Performance
Fujian Wanchen Biotechnology Co. Ltd (300972) trades on SHE in CNY. The company is classified in the Consumer Defensive sector under the Farm Products industry. The stock currently trades at CNY205.33, up 0.82% from the previous close.
Over the past year, 300972 has traded between a low of CNY127.91 and a high of CNY228.12. The stock has gained 57.9% over this period. It is currently 10.0% below its 52-week high.
Fujian Wanchen Biotechnology Co. Ltd has a market capitalization of $39.14B, with a price-to-earnings ratio of 30.18 and a dividend yield of 0.48%.
About Fujian Wanchen Biotechnology Co. Ltd
Fujian Wanchen Biotechnology Co., Ltd., together with its subsidiaries, engages in the research, development, cultivation, production, and sale of edible fungi in China and internationally. The company offers enoki and golden enoki, white jade, crab, seafood, deer antler, oyster, and other mushrooms products, as well as flammulina velutipes, hydrangea edulis, and pleurotus eryngii. It is also involved in breeding and fruit testing to produce new variants of edible fungi. The company sells its products through prefecture-level city and county level partners, supermarket chains, and e-commerce fresh food platforms. It exports its products. The company was founded in 2011 and is headquartered in Zhangpu, China.
Compare Fujian Wanchen Biotechnology Co. Ltd
Side-by-side comparison against top Consumer Defensive peers.
Company Info
- Sector
- Consumer Defensive
- Industry
- Farm Products
- Exchange
- SHE
- Currency
- CNY
- Country
- China
Financial Metrics
- Revenue (TTM)
- $51.46B
- EBITDA
- $3.26B
- Profit Margin
- 2.61%
- EPS (TTM)
- 6.78
- Book Value
- 7.85
Technical Indicators
- 52 Week High
- CN¥240.89
- 52 Week Low
- CN¥127.54
- 50 Day MA
- CN¥199.43
- 200 Day MA
- CN¥184.61
- Beta
- 0.07
Valuation
- Trailing P/E
- 30.18
- Forward P/E
- N/A
- Price/Sales
- 0.76
- Price/Book
- 27.15
- Enterprise Value
- $37.60B